Open AccessSystemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
Author(s) -
Sharon H. Giordano,
Maria Alice Franzoi,
Sarah Temin,
Carey K. Anders,
Sarat Chandarlapaty,
Jennie R. Crews,
Jeffrey J. Kirshner,
Ian E. Krop,
Nancy U. Lin,
Aki Morikawa,
Debra A. Patt,
Jane Perlmutter,
Naren Ramakrishna,
Nancy E. Davidson
Publication year - 2022
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.22.00519
Subject(s) - medicine , trastuzumab , pertuzumab , lapatinib , oncology , neratinib , metastatic breast cancer , taxane , clinical trial , cancer , guideline , breast cancer , systemic therapy , palbociclib , trastuzumab emtansine , targeted therapy , intensive care medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom